email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
1156 - 1170
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
Brii Bio Allocates $100 Million to Bring Dual SARS-CoV-2 mAb Therapy to Market
$5.00
Available
JW Therapeutics to Launch CD-19 CAR-T in China for Lymphoma
$5.00
Available
Arctic Vision Will Start Phase III Trial of Nearsightedness Therapy in China
$5.00
Available
Harbour BioMed to Start China Phase III Trial of Autoimmune Therapy
$5.00
Available
Innovent Acquires Rights to KRAS G12C Candidate in $312 Million Pact
$5.00
Available
NeuExcell Raises $10 Million For Gene Therapies Aimed at Neurodegenerative Repair
$5.00
Available
Jacobio Invests $53 Million into Hebecell and its Stem Cell Based CAR-T Therapies
$5.00
Available
ETERN Closes Funding to Advance Novel Technology for Undruggable Targets
$5.00
Available
GloriaBio Approved to Launch PD-1 in China for Hodgkin's Lymphoma
$5.00
Available
4B to Partner with Insilico to Develop Small Molecule ALS Treatments
$5.00
Available
Ionova Completes $100 Million Round for Targeted and Immuno Therapies
$5.00
Available
Microport EP and Stereotaxis Form Robotic Ablation Device Collaboration
$5.00
Available
Bio-Thera Sells US Rights to Autoimmune Biosimilar in $150 Million Deal
$5.00
Available
Lynk Raises $50 Million to Develop Small Molecule Drug Portfolio
$5.00
Available
Ocumension Acquires Two Novartis Products in $35 Million Agreement
$5.00
Available